DOT1L: Target Triple-Negative Breast Cancer (TNBC) Stem Cells
Physician's Weekly,
For a study, researchers sought to see if blocking DOT1L, an epigenetic regulator of normal tissue stem/progenitor populations…
DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast CancerDOT1Li Targets TNBC Stem Cells
Overview of attention for article published in Clinical Cancer Research, February 2022
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (89th percentile)
-
Good Attention Score compared to outputs of the same age and source (66th percentile)
Readers on
- mendeley
- 68 Mendeley